ALPS Advisors’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $327K | Sell |
143,614
-56,095
| -28% | -$128K | ﹤0.01% | 904 |
|
2025
Q1 | $310K | Sell |
199,709
-15,481
| -7% | -$24K | ﹤0.01% | 893 |
|
2024
Q4 | $506K | Buy |
+215,190
| New | +$506K | ﹤0.01% | 602 |
|
2023
Q4 | – | Sell |
-128,147
| Closed | -$299K | – | 966 |
|
2023
Q3 | $299K | Buy |
128,147
+927
| +0.7% | +$2.16K | ﹤0.01% | 883 |
|
2023
Q2 | $303K | Buy |
+127,220
| New | +$303K | ﹤0.01% | 866 |
|
2022
Q4 | – | Sell |
-49,657
| Closed | -$106K | – | 1030 |
|
2022
Q3 | $106K | Sell |
49,657
-4,274
| -8% | -$9.12K | ﹤0.01% | 1028 |
|
2022
Q2 | $153K | Sell |
53,931
-39,502
| -42% | -$112K | ﹤0.01% | 1006 |
|
2022
Q1 | $390K | Buy |
93,433
+9,051
| +11% | +$37.8K | ﹤0.01% | 492 |
|
2021
Q4 | $438K | Buy |
+84,382
| New | +$438K | ﹤0.01% | 569 |
|